Clinical Scorecard: Oculis CEO Riad Sherif, MD
At a Glance
| Category | Detail |
|---|---|
| Condition | Acute Optic Neuritis |
| Key Mechanisms | Neuroprotective treatment aimed at preserving retinal ganglion cells and axons. |
| Target Population | Patients with acute optic neuritis, often associated with multiple sclerosis. |
| Care Setting | Clinical trial setting, specifically a phase 2 randomized controlled trial. |
Key Highlights
- Privosegtor (OCS-05) demonstrated cardiac safety with no significant adverse events compared to placebo.
- Reduced multiple sclerosis relapses (10.5% vs 35.7%) in patients treated with OCS-05 plus steroids.
- Preserved retinal ganglion cell and nerve fiber layer thickness, indicating neuroprotective effects.
- Improved low-contrast visual acuity in patients receiving OCS-05 compared to steroid treatment alone.
- Potential for broader applications in neurodegenerative diseases beyond acute optic neuritis.
Guideline-Based Recommendations
Diagnosis
- Diagnosis of acute optic neuritis typically involves clinical evaluation and imaging studies.
Management
- Consider OCS-05 as a neuroprotective therapy in conjunction with steroids for acute optic neuritis.
Monitoring & Follow-up
- Monitor visual function and retinal thickness in patients receiving treatment.
Risks
- Assess for potential adverse effects related to steroid use and monitor for MS relapse rates.
Patient & Prescribing Data
Patients diagnosed with acute optic neuritis, particularly those with or at risk for multiple sclerosis.
OCS-05 may offer a novel approach to preserving vision and preventing neuronal loss.
Clinical Best Practices
- Integrate OCS-05 into treatment protocols for acute optic neuritis where applicable.
- Conduct thorough patient assessments to identify those who may benefit from neuroprotective therapies.
- Stay updated on ongoing research and developments regarding OCS-05 and its potential indications.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.